A study comparing apoB against standard LDL tests and how that choice affects treatment decisions and healthcare costs.
Key Takeaways
- Researchers modeled stepped treatment escalating statins then adding ezetimibe when targets missed
- ApoB-guided therapy prevented more heart attacks and strokes than LDL-guided care
- ApoB strategy improved overall health outcomes while remaining cost-effective for U.S